We are live on !
Find out more
Foundry Partners Portfolio holdings
AUM
$1.89B
Turnover
15.38%
1-Year Est. Return
9.84%
This Fund
S&P 500
This Quarter Est. Return
+2.33%
1 Year Est. Return
+9.84%
3 Year Est. Return
+44.42%
5 Year Est. Return
+233.05%
10 Year Est. Return
+297.72%
AUM
$2.4B
AUM Growth
+$79.8M
(+3.4%)
Cap. Flow
+$53.8M
Cap. Flow % of AUM
Cap. Flow %
2.24%
Top 10 Holdings %
Top 10 Hldgs %
10.01%
Holding
463
New
25
Increased
166
Reduced
240
Closed
30
Avg Time Held
1.3
years
Top 10 Avg Time Held
0.6
years
Top 20 Avg Time Held
0.7
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$12.2M |
| 2 |
HP
HPQ
|
+$10M |
| 3 |
LXP Industrial Trust
LXP
|
+$9.44M |
| 4 |
Generac Holdings
GNRC
|
+$8.78M |
| 5 |
Nucor
NUE
|
+$8.72M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$19.6M |
| 2 |
MENT
Mentor Graphics Corp
MENT
|
+$10.3M |
| 3 |
Apple
AAPL
|
+$10M |
| 4 |
ENH
Endurance Specialty Holdings Ltd
ENH
|
+$9.8M |
| 5 |
Altria Group
MO
|
+$7.62M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 26.18% |
| 2 | Industrials | 16.93% |
| 3 | Technology | 14.24% |
| 4 | Consumer Discretionary | 9.54% |
| 5 | Healthcare | 8.54% |
Similar funds
PAME
Foundry Partners's Q1 2017 Portfolio in Review
As of Q1 2017, Foundry Partners held 463 positions worth $2.4B, up 3.4% from $2.32B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Foundry Partners's Q1 2017 filing shows 25 new, 166 increased, 240 reduced and 30 closed positions. Its largest new stake was Abbott: 283,085 shares worth $12.6M. The largest sale was Pfizer, an estimated $19.6M.
By sector, the portfolio is most concentrated in Financials at 26% of assets, down from 28% a quarter earlier, followed by Industrials and Technology.
- Foundry Partners's largest Q1 2017 buy was Abbott: 283,085 shares worth $12.6M.
- Foundry Partners added most to LXP Industrial Trust in Q1 2017, an estimated $9.44M increase.
- Foundry Partners's biggest Q1 2017 reduction was Apple, cutting an estimated $10M.
- Foundry Partners fully exited Pfizer in Q1 2017, selling an estimated $19.6M.
- Foundry Partners's ten largest holdings make up 10% of its $2.4B portfolio in Q1 2017.
- Foundry Partners opened 25 new positions and closed 30 in Q1 2017.
- Foundry Partners's portfolio value rose 3.4% quarter-over-quarter to $2.4B.
Based on Foundry Partners's 13F filing for Q1 2017, filed 4 Apr 2017.